[Pharmacoeconomic Comparison Between Dupilumab and Tralokinumab for the Treatment of Atopic Dermatitis in Italy: A Cost-per-Responder Analysis]. FE [Internet]. 2025 May 8 [cited 2025 Oct. 29];26(1). Available from: https://journals.seedstm.com/index.php/FE/article/view/1571